Fortress Biotech, Inc.
US ˙ NasdaqCM ˙ US34960Q3074

SecurityFBIO / Fortress Biotech, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership63,692 shares
Latest Disclosed Value $ 233,113
Group One Trading, L.p. ownership in FBIO / Fortress Biotech, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 63,692 shares of Fortress Biotech, Inc. (US:FBIO) valued at $233,113 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 15,382 shares of Fortress Biotech, Inc.. This represents a change in shares of 314.07% during the quarter. The current value of the position is $176,427 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (FBIO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FBIO / Fortress Biotech, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F FORTRESS BIOTECH COM NEW 34960Q307 63,692 48,310 314.07 233 316.07 0.0004
2025-11-12 2025-09-30 13F FORTRESS BIOTECH COM NEW 34960Q307 15,382 15,382 57 0.0001
2025-08-14 2025-06-30 13F FORTRESS BIOTECH COM NEW 34960Q307 0 -44,820 -100.00 0 -100.00
2025-05-14 2025-03-31 13F FORTRESS BIOTECH COM NEW 34960Q307 44,820 15,124 50.93 70 15.00 0.0002
2025-05-14 2024-12-31 13F/A-1 FORTRESS BIOTECH COM NEW 34960Q307 29,696 4,000 15.57 60 62.16 0.0001
2025-02-14 2024-12-31 13F FORTRESS BIOTECH COM NEW 34960Q307 29,696 4,000 60 0.0001
2024-11-14 2024-09-30 13F FORTRESS BIOTECH COM NEW 34960Q307 25,696 14,800 135.83 37 105.56 0.0001
2024-08-14 2024-06-30 13F FORTRESS BIOTECH COM NEW 34960Q307 10,896 10,000 1,116.07 19 1,700.00 0.0001
2024-05-10 2024-03-31 13F FORTRESS BIOTECH COM NEW 34960Q307 896 863 2,615.15 2 0.0000
2024-02-14 2023-12-31 13F FORTRESS BIOTECH COM NEW 34960Q307 33 33 0 0.0000
2015-02-11 2014-12-31 13F CORONADO BIOSCIENCES COM 21976U109 0 -128,184 -100.00 0 -100.00
2014-10-31 2014-09-30 13F CORONADO BIOSCIENCES COM 21976U109 128,184 24,708 23.88 269 51.12 0.0041
2014-08-12 2014-06-30 13F CORONADO BIOSCIENCES COM 21976U109 103,476 91,469 761.80 178 456.25 0.0027
2014-01-31 2013-12-31 13F CORONADO BIOSCIENCES COM 21976U109 12,007 8,540 246.32 32 33.33 0.0005
2013-11-15 2013-09-30 13F CORONADO BIOSCIENCES COM 21976U109 3,467 -32,733 -90.42 24 -92.28 0.0005
2013-08-02 2013-06-30 13F CORONADO BIOSCIENCES COM 21976U109 36,200 36,200 311 0.0077
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-11-12 2021-09-30 13F FORTRESS BIOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F FORTRESS BIOTECH COM Call 7,000 25 n/a n/a n/a
2018-11-08 2018-09-30 13F FORTRESS BIOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F FORTRESS BIOTECH COM Call 15,200 0.00 45 -34.78 n/a n/a n/a
2018-05-16 2018-03-31 13F/A FORTRESS BIOTECH COM Call 15,200 245.45 69 283.33 n/a n/a n/a
2018-05-10 2018-03-31 13F FORTRESS BIOTECH COM Call 15,200 69 n/a n/a n/a
2018-02-09 2017-12-31 13F FORTRESS BIOTECH COM Call 4,400 -41.33 18 -45.45 n/a n/a n/a
2017-11-15 2017-09-30 13F FORTRESS BIOTECH COM Call 7,500 -61.73 33 -64.52 n/a n/a n/a
2017-08-14 2017-06-30 13F FORTRESS BIOTECH COM Call 19,600 6,433.33 93 9,200.00 n/a n/a n/a
2017-05-10 2017-03-31 13F FORTRESS BIOTECH COM Call 300 -98.47 1 -98.92 n/a n/a n/a
2017-02-15 2016-12-31 13F FORTRESS BIOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F FORTRESS BIOTECH COM Call 20,000 59 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-11 2022-03-31 13F FORTRESS BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-11 2021-12-31 13F FORTRESS BIOTECH COM Put 20,000 100.00 50 56.25 n/a n/a n/a
2021-11-12 2021-09-30 13F FORTRESS BIOTECH COM Put 10,000 -42.53 32 -48.39 n/a n/a n/a
2021-08-10 2021-06-30 13F FORTRESS BIOTECH COM Put 17,400 62 n/a n/a n/a
2019-02-05 2018-12-31 13F FORTRESS BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F FORTRESS BIOTECH COM Put 5,000 0.00 8 -46.67 n/a n/a n/a
2018-08-13 2018-06-30 13F FORTRESS BIOTECH COM Put 5,000 0.00 15 87.50 n/a n/a n/a
2017-02-15 2016-12-31 13F FORTRESS BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F FORTRESS BIOTECH COM Put 79,800 237 n/a n/a n/a
2015-11-06 2015-09-30 13F FORTRESS BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-11 2015-06-30 13F FORTRESS BIOTECH COM Put 200 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.